Inhibrx Biosciences, Inc. INXB
We take great care to ensure that the data presented and summarized in this overview for Inhibrx Biosciences, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in INXB
Top Purchases
Top Sells
About INXB
Insider Transactions at INXB
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2025
|
Jon Faiz Kayyem Director |
SELL
Bona fide gift
|
Indirect |
90,000
-17.67%
|
-
|
|
Dec 16
2024
|
Jon Faiz Kayyem Director |
BUY
Bona fide gift
|
Indirect |
500,000
+50.0%
|
-
|
|
Dec 16
2024
|
Jon Faiz Kayyem Director |
SELL
Bona fide gift
|
Indirect |
500,000
-49.54%
|
-
|
|
Dec 06
2024
|
Jon Faiz Kayyem Director |
SELL
Bona fide gift
|
Indirect |
52,000
-4.9%
|
-
|
|
Nov 20
2024
|
Jon Faiz Kayyem Director |
BUY
Open market or private purchase
|
Indirect |
37,500
+21.16%
|
$525,000
$14.19 P/Share
|
|
Nov 19
2024
|
Jon Faiz Kayyem Director |
BUY
Open market or private purchase
|
Indirect |
69,686
+40.55%
|
$975,604
$14.23 P/Share
|
|
Oct 03
2024
|
Kristiina Md Vuori Director |
BUY
Open market or private purchase
|
Direct |
6,667
+24.59%
|
$100,005
$15.0 P/Share
|
|
Sep 16
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
13,037
+1.81%
|
$221,629
$17.13 P/Share
|
|
Sep 12
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
26,963
+3.75%
|
$404,445
$15.05 P/Share
|
|
Sep 11
2024
|
Kristiina Md Vuori Director |
BUY
Open market or private purchase
|
Direct |
6,457
+31.91%
|
$96,855
$15.07 P/Share
|
|
Sep 10
2024
|
Kristiina Md Vuori Director |
BUY
Open market or private purchase
|
Direct |
179
+2.39%
|
$2,685
$15.0 P/Share
|
|
Sep 10
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
8,500
+1.26%
|
$127,500
$15.19 P/Share
|
|
Sep 09
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
9,500
+1.43%
|
$142,500
$15.21 P/Share
|
|
Sep 06
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
26,000
+3.86%
|
$390,000
$15.29 P/Share
|
|
Sep 03
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
20,000
+5.74%
|
$300,000
$15.99 P/Share
|
|
Aug 30
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+6.45%
|
$140,000
$14.02 P/Share
|
|
Aug 29
2024
|
Mark Lappe Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+6.9%
|
$140,000
$14.03 P/Share
|
|
Aug 29
2024
|
Kristiina Md Vuori Director |
BUY
Open market or private purchase
|
Direct |
7,140
+50.0%
|
$99,960
$14.0 P/Share
|
|
Aug 28
2024
|
Kimberly Manhard Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$130,000
$13.98 P/Share
|
|
Aug 23
2024
|
Douglas Forsyth Director |
BUY
Open market or private purchase
|
Indirect |
59,812
+21.03%
|
$837,368
$14.07 P/Share
|
Last 12 Months Summary
Buy / Acquisition
877K
Shares
From
6
Insiders
| Open market or private purchase | 377K shares |
|---|---|
| Bona fide gift | 500K shares |
Sell / Disposition
642K
Shares
From
1
Insiders
| Bona fide gift | 642K shares |
|---|